Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro (NYSE: NVRO), a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a result, the stock gained 21% on Thursday.

After the bell on Wednesday, Nevro told investors that third-quarter revenue reached $100.2 million, which was $7.9 million more than the average analyst was expecting. On the bottom line, the consensus estimate for earnings was a loss of $0.84, but the company narrowed its loss to just $0.58 per share.

Image source: Getty Images.

Source Fool.com